Guangdong Hybribio Biotech Co (SZSE:300639) Marketable Securities : ¥280.1 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Guangdong Hybribio Biotech Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Guangdong Hybribio Biotech Co's Marketable Securities for the quarter that ended in Mar. 2024 was ¥280.1 Mil.

Guangdong Hybribio Biotech Co's annual Marketable Securities declined from Dec. 2021 (¥677.1 Mil) to Dec. 2022 (¥387.1 Mil) and declined from Dec. 2022 (¥387.1 Mil) to Dec. 2023 (¥307.1 Mil).

Guangdong Hybribio Biotech Co Marketable Securities Historical Data

The historical data trend for Guangdong Hybribio Biotech Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangdong Hybribio Biotech Co Marketable Securities Chart

Guangdong Hybribio Biotech Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

5.00

860.00

677.14

387.06

307.06

Guangdong Hybribio Biotech Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															373.10	265.30	277.05	307.06	280.06

Guangdong Hybribio Biotech Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Guangdong Hybribio Biotech Co (SZSE:300639) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Guangdong Hybribio Biotech Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of Guangdong Hybribio Biotech Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Guangdong Hybribio Biotech Co (SZSE:300639) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Guangdong Hybribio Biotech Co Ltd (SZSE:300639) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

D 5-3-3-4, North High-tech Zone, Economic Development Zone, Chaozhou City, CHN, 521000

Website

http://www.hybribio.cn

Guangdong Hybribio Biotech Co Ltd is a Chinese company engaged in offering vitro diagnostic assays. Its products include in-vitro diagnostic kits, female sample collection kit, DNA extraction kit, and other devices. The company's products help in the infectious pathogens detection and genetic disease detection, including human papillomavirus, thalassemia, G6PD, hearing loss susceptibility, phenylketonuria, and early cancer detection, among others. The company has a business presence in China and various other countries.

Guangdong Hybribio Biotech Co (SZSE:300639) Headlines

No Headlines